Development of a Non-Invasive Prognostic Test for Graves Orbitopathy
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 90
- 试验地点
- 1
- 主要终点
- Biomarkers found in tears collected at Baseline
研究概览
简要总结
The aim of this research project is to develop a non-invasive, simple, robust, and sensitive prognostic test that can identify hyperthyroidism patients who are at risk of developing Graves' Orbitopathy. This phase of the study is a research phase in which we analyze blood samples and tear fluid using standard laboratory equipment and software. The aim is to identify biomarkers that can detect patients at risk of developing Graves' Orbitopathy. Offering more personalized advice, treatment, and follow-up could potentially prevent the clinical consequences or limit their severity.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Parallel
- 主要目的
- Supportive Care
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •healthy control OR diagnosis of hyperthyroidism OR diagnosis of Graves' Orbitopathy
排除标准
- 未提供
研究组 & 干预措施
Healthy controls
Schirmer's test
干预措施: Schirmer's test (Other)
Hyperthyroidism
Schirmer's test
干预措施: Schirmer's test (Other)
Graves' Orbitopathy
Schirmer's test
干预措施: Schirmer's test (Other)
结局指标
主要结局
Biomarkers found in tears collected at Baseline
时间窗: Baseline
During a one-day study visit (Baseline visit), tears will be collected from all study participants via a Schirmer's test.
次要结局
未报告次要终点